Connectivity
Demand Generation
Brand Awareness
Thought Leadership
L'un des aspects les plus appréciés de twin casino est sa capacité à offrir une expérience personnalisée à chaque joueur. Les événements en direct spéciaux, comme les soirées thématiques, apportent une dimension festive aux sessions de jeu. Le système anti-fraude avancé protège les joueurs contre toute tentative de manipulation ou d'usurpation. La section des nouveautés met en lumière les dernières sorties pour que les joueurs ne manquent aucun lancement. Le parcours sans faute de cette plateforme en fait un modèle à suivre dans l'industrie du casino en ligne.
Ce qui frappe en premier chez https://betcliccasino.org, c'est la variété impressionnante des jeux de casino accessibles en quelques clics. Les jeux de crash et les options de paris rapides séduisent les joueurs en quête de sensations immédiates. L'inscription est rapide et ne nécessite que quelques étapes simples pour commencer à jouer. Les jeux de type megaways offrent des milliers de lignes de paiement pour des combinaisons quasi infinies. Avec des fondations aussi solides, cette plateforme est bien partie pour rester un incontournable du secteur.
March 5th 2026 - 16:00pm (CET) / 10:00am (ET)
The era of protein therapeutics began in the 1980s with recombinant insulin, transforming modern medicine. Today, we are witnessing another groundbreaking shift with the rise of nucleic acid therapeutics (NAT).
March 25th 2026 - 15:00 (GMT) / 10:00 (ET)
Join our experts for a practical webinar on scaling up OSD manufacturing for late-phase success. You’ll learn how to strengthen process understanding and choose a CDMO partner who can take you from clinical to commercial.
November 18th 2025 - 16:00pm (CET) / 10:00am (ET)
The quantification of subvisible particles is a critical aspect of ensuring the safety, efficacy, and overall quality of pharmaceutical products. These particles may originate from extrinsic sources, e.g., environmental contaminants or manufacturing equipment, or be intrinsic to the formulation itself.
November 13th 2025 – 16:00 CET / 10:00 ET
As pharmaceutical companies face increasing pressure to optimize R&D investments and extend the lifecycle of existing assets, drug repositioning has emerged as a strategic pathway to unlock new therapeutic opportunities. This webinar explores how repositioning—whether through new indications, formulations, or delivery routes—can drive innovation, accelerate development timelines, and expand market reach.
October 1st 2025 - 15:00 (BST) / 10:00 (ET)
Unlock the potential of nasal drug delivery for Central Nervous System (CNS) therapies in this expert-led webinar. With increasing focus on non-invasive routes and the promise of direct nose-to-brain transport, the nasal pathway presents both exciting opportunities and complex challenges.
September 16th 2025 - 17:00 (CET) / 11:00 (EST)
Medication adherence is a critical driver of success in drug development and a fundamental component of trial integrity. Poor adherence introduces variability and bias that can obscure the true efficacy and safety of an investigational product, jeopardizing trial outcomes, regulatory decisions, and ultimately, patient care.
September 10th, 2025– 16:00 (CET) / 10am (ET)
Transmucosal drug delivery has advanced significantly over recent decades—from simple liquid formulations to sophisticated mucoadhesive buccal films. Today, technologies such as Mucofilm® provide an effective solution for APIs with poor oral bioavailability, sensitive degradation profiles, or a need for rapid onset of action.
September 18th, 2025 – 4pm (CET) / 10am (ET)
Intravitreal injections involve direct delivery into a highly sensitive area, presenting additional requirements and challenges compared to conventional parenteral injections, such as subcutaneous or intramuscular. Careful consideration is essential in selecting an appropriate drug delivery system to ensure the safe and effective treatment of eye disorders.
July 1st 2025 - 16:00pm (CET) / 10:00am (ET)
The development of new protein therapeutics is a complex and costly process, often hindered by late-stage failures due to poor drug-like properties or instability of drug candidates.
July 9th, 2025 – 4pm (CET) / 10:00am (ET)
The delivery of therapeutic aerosols via the respiratory tract is key for treating diseases or provide airway hygiene and the drug or medical device can only be successful if the application technology is functional for the target group and the formulation.
June 25th 2025 - 15:00pm (BST) / 10:00am (ET)
This webinar explores how evaluating the right CDMO partner can help position your liquid and powder sterile product for success at each stage of the development process.
May 29th, 2025 – 16:00pm (CET) / 10am (ET)
Preclinical studies form the cornerstone of drug development, providing critical data on feasibility and safety before human trials begin. Whilst regulatory bodies like FDA and EMA offer scientific guidelines for non-clinical testing, the selection of appropriate drug delivery systems remains unstandardised—yet plays a crucial role in study outcomes and translational success.
June 5th, 2025 – 16:00pm (CEST) / 10am (EDT)
Rapid and cost-effective development of early-phase drug candidates is important in progressing molecules to first-in-human (FIH) trials. A common challenge is that many new chemical entities (NCEs) suffer from poor bioavailability because of their low aqueous solubility.
April 8th 2025 – 4pm (CET) / 10am (ET)
Particulate and microbial contamination are major causes of FDA recalls, posing significant risks to patients. The European Medicine Agency updated Annex 1 of the Good Manufacturing Practices sets to tackle these considerations to improve patient safety, which is putting Pharma companies under pressure for implementing new processes and complying to these new standards.
November 29th, 2023 - 4pm (CET) / 10am (ET)
Particles in the visible and subvisible size range can appear in (bio)pharmaceutical samples and drug products during all stages of development and even after market approval.
February 21st, 2024 - 4pm (CET) / 10am (ET)
This webinar will cover common issues during the development for different biologics drug product presentations. The experts will be highlighting how DP and Clinical Development are linked, going into detail about phase-appropriate actions taken as part of the roadmap.
March 7, 2024 – 3pm (GMT) / 10am (ET)
Explore the nuances of capsules, packaging materials, and process equipment in OSD manufacturing. Overcome common OSD formulation challenges and gain insights into cost-effective scale-up processes.
May 8, 2024 - 11am (ET) / 10am (ET)
Unlock the full potential of Oral Solid Dosage (OSD) manufacturing by diving into the intricacies of capsules, packaging materials, and process equipment, overcoming formulation challenges, and mastering cost-effective scale-up processes.
May 7, 2024 – 4pm (CET) / 10am (ET)
Dive into the critical realm of surfactants with our engaging webinar, shedding light on their significance in biologics and gene & cell therapy formulation development.
April 10th, 2025 – 4pm (CET) / 10am (ET)
This webinar will explore the limitations of current drug delivery methods, focusing on challenges such as volume constraints, patient comfort, and adherence. Using the Sorrel OBDS platform as a case study, we will highlight its role in the development of the UDENYCA On-body injector.
June 27th, 2024 - 4pm (CET) / 10am (ET)
Discover the transformative journey of preservative-free spray systems in the pharmaceutical industry over three decades, delving into the benefits across pharmaceuticals, medical devices, and cosmetics, alongside a deep dive into regulatory landscapes like the EU’s MDR for drug-device combinations.
July 11th, 2024 – 4pm (CET) / 10am (ET)
In this webinar, Enrico Barichello, Product Manager for Syringe Platform in Stevanato Group and Alan Xu, Product Manager for Analytical Services in Stevanato Group, will be discussing the best strategy between customers and suppliers to select the right container based on the key features of the combination product.
July 10th, 2024 – 4pm (CET) / 10am (ET)
Discover advanced lyo modelling techniques to enhance freeze-drying processes and improve pharmaceutical product quality. Gain valuable insights from industry experts in this focused session.
October 1st, 2024 – 4pm (CET) / 10am (ET)
Join us for an insightful webinar, Sharpening the Future – New Opportunities for Implant Injection. This session is perfect for healthcare professionals, industry experts, and anyone interested in the future of medical implants.
November 20th, 2024 – 4pm (CET) / 10am (ET)
In this webinar, Prof. Dr. Susumu Uchiyama will provide an overview of today’s state-of-the art analytical methods for AAV characterization and address key parameters to monitor during process development in AAV manufacturing.
October 22nd, 2024 – 4pm (CET) / 10am (ET)
Join our webinar to navigate the complexities of clinical studies for Orally Inhaled and Nasal Drug Products (OINDPs). Learn how to balance preparation, mitigate risks in CMC studies, and collaborate with experts to optimise development and meet regulatory requirements
November 14th, 2024 – 4pm (CET) / 10am (ET)
In this webinar, our speakers will be discussing the critical aspects of GMP Annex 1 Implementation. They will cover essential topics such as compliance and sterility assurance, flexible sterile capacity, and effective risk mitigation strategies.
February 27th, 2025 – 4pm (CET) / 10am (ET)
This webinar explores best practices for identifying and selecting the most developable lead candidates, defining the formulation corridor through robust pre-formulation screening, and incorporating clinical in-use stability testing to de-risk your strategy
February 26th 2025 – 3pm (GMT) / 10am (ET)
In this webinar, Dr. Ian Lafferty will explore practical approaches and proven techniques for refining formulations, managing Phase 1 outcomes, and optimising development timelines. Real-world examples bring clarity to these complex processes, enabling you to navigate common obstacles with confidence.